All opportunities
Internal Opportunity
Full-time, Permanent
Remote (U.S.-based), with regular executive presence in Pittsburgh as required
C-Suite / Executive Leadership
Biotechnology, Life Sciences, Pharmaceutical Research, Medical Devices and Surgical Therapeutics

Chief Financial Officer (CFO)

Employer
Peptilogics, Inc.
Industry
Biotechnology, Life Sciences, Pharmaceutical Research, Medical Devices and Surgical Therapeutics
Location
Pittsburgh, Pennsylvania, United States / U.S.-based Remote
Country
United States
Work arrangement
Remote (U.S.-based), with regular executive presence in Pittsburgh as required
Employment type
Full-time, Permanent
Seniority
C-Suite / Executive Leadership
Department
Executive Leadership / Finance
Application status
Accepting applications
Closing date
2026-11-30
Closes in–d –h –m –s· Friday, 27 November 2026 at 23:59 (UTC)

Your application is received by Westbridge for review. We do not automatically forward materials to an employer.

About the role

The Chief Financial Officer will provide strategic and operational financial leadership during a significant development stage for Peptilogics.

The executive will be responsible for developing the company's long-term financial strategy, managing capital allocation, overseeing financing activities, and strengthening financial infrastructure to support clinical development and future corporate growth.

Working closely with the CEO and Board of Directors, the CFO will lead institutional fundraising strategies, venture debt arrangements, financial governance, investor engagement, and preparation for potential public-market or strategic liquidity opportunities.

The role requires an executive who can combine sophisticated capital markets expertise with hands-on financial leadership in a milestone-driven biotechnology or medical technology environment.

The CFO will also oversee financial planning and analysis, accounting, audit, tax, treasury, financial systems, and enterprise risk management.

Company overview

Peptilogics, Inc. is a clinical-stage surgical therapeutics company developing engineered peptide-based treatments designed to prevent and treat medical device-related infections.

The company's proprietary computational peptide discovery platform focuses on biofilm-driven bacterial infections associated with implanted medical hardware.

Its lead development candidate, zaloganan (PLG0206), is being developed for prosthetic joint infections, addressing an area of significant unmet medical need.

The company operates within the biotechnology, pharmaceutical research, and medical technology sectors.

Company information and clinical development details should be independently reconfirmed before public publication.

Key responsibilities

Develop and execute the company's long-term financial and capitalization strategy.

Lead institutional equity financings, venture debt arrangements, and other capital-raising initiatives.

Oversee non-dilutive funding opportunities and government financing programs.

Support strategic licensing, mergers, acquisitions, and corporate development transactions.

Build and maintain institutional-grade financial reporting and accounting infrastructure.

Establish appropriate internal financial controls and SOX-compliant processes.

Prepare the organization for potential IPO, reverse merger, or strategic liquidity transactions.

Lead investor relations and communicate financial strategy to institutional investors.

Develop relationships with healthcare investment banks and strategic financial partners.

Direct financial planning, budgeting, forecasting, and long-range financial modelling.

Manage clinical development expenditure, cash runway, and capital allocation.

Oversee treasury, accounting, taxation, external audits, and financial compliance.

Lead ERP modernization and financial systems development.

Introduce predictive analytics and AI-enabled financial workflows.

Establish enterprise risk management and insurance programmes.

Provide financial leadership and strategic advice to the CEO and Board of Directors.

Oversee and develop the company's finance and accounting leadership team.

Candidate profile

The ideal candidate will be an accomplished senior finance executive with substantial experience leading financial operations within biotechnology, life sciences, pharmaceutical, or medical device organizations.

Candidates should demonstrate the ability to manage complex financial structures, lead institutional fundraising, oversee corporate governance, and support organizations through significant clinical, commercial, and strategic development milestones.

The successful executive will possess strong commercial judgment, board-level communication skills, and the ability to balance scientific investment priorities with financial discipline.

Previous experience as a CFO, senior finance executive, or capital markets leader within a growth-stage or publicly listed life sciences organization is highly relevant.

The role requires an executive capable of taking direct ownership of financial strategy, capital formation, investor relations, and enterprise financial governance.

Required qualifications

Bachelor's degree in Finance, Accounting, Economics, or a related discipline.

At least 15 years of progressive financial leadership experience.

Substantial financial leadership experience in biotechnology, life sciences, pharmaceutical, or medical device organizations.

Previous public-company CFO experience or significant senior capital markets leadership.

Demonstrated experience in institutional fundraising, equity financing, and venture debt.

Strong understanding of U.S. GAAP, financial reporting, and audit governance.

Knowledge of SOX compliance and public-company financial controls.

Experience managing financial operations within clinical-stage or milestone-driven organizations.

Demonstrated ability to engage with CEOs, Boards of Directors, investors, and external financial stakeholders.

Strong strategic planning, financial modelling, and executive communication capabilities.

Preferred qualifications

MBA, CPA, CFA, or equivalent advanced financial qualification.

Experience supporting surgical therapeutics, anti-infective, orthopedic, or medical device businesses.

Exposure to late-stage Phase 3 clinical trials and commercial launch preparation.

Established relationships with institutional biotechnology and medical technology investors.

Experience working with healthcare investment banks and strategic business development teams.

Previous involvement in IPO preparation, reverse mergers, venture debt, or institutional equity offerings.

Experience developing finance functions within clinical-stage biotechnology organizations.

Knowledge of SEC reporting, SOX compliance, and public-company financial governance.

Experience with international clinical development budgets and multi-year financial planning.

Compensation & benefits

PROPOSED EXECUTIVE COMPENSATION — SUBJECT TO CLIENT CONFIRMATION

Indicative annual base salary: $440,000–$485,000 USD.

Annual performance bonus: 40% target, with potential stretch bonus up to 60%.

Proposed executive equity: 0.75%–1.25%, subject to final agreement and company valuation.

Proposed vesting schedule: Four years.

Potential estimated total annual compensation: $825,000–$1,050,000+, inclusive of estimated annualized equity valuation. Actual realized value will depend on company valuation, financing, vesting, and liquidity.

Proposed executive benefits:

- Medical, dental, and vision coverage.

- 401(k) with employer matching.

- Executive life and disability insurance.

- Flexible executive paid time off.

All compensation figures, equity arrangements, benefits, and incentive structures are proposed mandate parameters and have not been independently confirmed or established as approved client terms. They must be verified before publication or candidate representation.

Work arrangements

Arrangement: Remote (U.S.-based), with regular executive presence in Pittsburgh as required

Location: Pittsburgh, Pennsylvania, United States / U.S.-based Remote

Primary location: Pittsburgh, Pennsylvania, United States.

Remote eligibility: U.S.-based remote arrangement is proposed.

Executive attendance: Regular executive presence may be required for Board meetings, investor roadshows, leadership offsites, and strategic business meetings.

Travel: Domestic travel as required for executive responsibilities, investor engagement, and corporate activities.

Relocation: Not specified; subject to client confirmation.

Final working arrangements and eligible remote locations must be confirmed with the client.

Reporting structure

Reporting line: Chief Executive Officer, Jonathan Steckbeck, Ph.D., with direct engagement with the Board of Directors and Audit Committee.

Department: Executive Leadership / Finance

Application instructions

Interested executives should submit an up-to-date CV or executive résumé through the Westbridge Search application process. Qualified applicants may be invited to participate in a confidential preliminary consultation with the executive search team. The initial discussion will assess financial leadership experience, capital markets exposure, board-level governance experience, career objectives, and potential alignment with the mandate. Shortlisted candidates may progress to confidential discussions with the client CEO and relevant Board representatives. All candidate information and discussions will be handled confidentially.

Independent analysis

INTERNAL SEARCH ASSESSMENT — NOT FOR PUBLICATION This mandate is positioned as a senior C-suite financial leadership appointment within a clinical-stage biotechnology organization. The strongest candidates are likely to have: - Previous CFO or equivalent executive finance leadership experience. - Direct responsibility for institutional fundraising and capital strategy. - Experience with venture-backed biotechnology or medical technology companies. - Public-market preparation and financial governance experience. - Board and Audit Committee engagement. - Experience managing financial operations through clinical development milestones. Potential candidate alignment should be assessed against the depth of direct capital-raising responsibility, experience with public-market transactions, and ability to transition from fractional advisory work into a full-time CFO appointment. IMPORTANT VERIFICATION REQUIREMENTS: 1. Confirm that Peptilogics has formally authorized Westbridge Search to conduct this appointment. 2. Confirm that the CFO vacancy currently exists. 3. Verify the reported clinical trial stage and regulatory designations. 4. Confirm the reporting structure and executive responsibilities. 5. Obtain written approval for salary, bonus, equity, and benefits. 6. Confirm the remote working arrangement and travel expectations. The supplied mandate is a proposed executive search document and does not independently establish client authorization or approved employment terms.

Interested in this role?

Westbridge reviews role enquiries and responds with relevant information about the opportunity and its application process.

Ask about this role →

More opportunities

Loading roles…